Literature DB >> 14256068

BEHAVIORAL AND METABOLIC CHANGES ASSOCIATED WITH ADMINISTRATION OF TETRAETHYLTHIURAM DISULFIDE (ANTABUSE).

R G HEATH, W NESSELHOF, M P BISHOP, L W BYERS.   

Abstract

Entities:  

Keywords:  AUTONOMIC NERVOUS SYSTEM; BLOOD CHEMICAL ANALYSIS; BODY WEIGHT; DISULFIRAM; ELECTROENCEPHALOGRAPHY; METABOLISM; PHARMACOLOGY; PSYCHOLOGICAL TESTS; PSYCHOPHARMACOLOGY; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TOXICOLOGIC REPORT; URINE

Mesh：

Substances：

Year:  1965        PMID： 14256068

Source DB:  PubMed          Journal:  Dis Nerv Syst        ISSN： 0012-3714


× No keyword cloud information.
  6 in total

1.  Vulnerability to disulfiram psychosis.

Authors:  H A Nasrallah
Journal:  West J Med       Date:  1979-06

2.  Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice.

Authors:  Brooke N Bourdélat-Parks; George M Anderson; Zoe R Donaldson; Jay M Weiss; Robert W Bonsall; Milburn S Emery; L Cameron Liles; David Weinshenker
Journal:  Psychopharmacology (Berl)       Date:  2005-10-22       Impact factor: 4.530

3.  The activities of brain dopamine-beta-hydroxylase and catechol-O-methyl transferase in schizophrenics and controls.

Authors:  A J Cross; T J Crow; W S Killpack; A Longden; F Owen; G J Riley
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

Review 4.  Epilepsy and schizophrenia: a neurochemical bridge.

Authors:  F Lamprecht
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

5.  Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer's disease hallmarks.

Authors:  Sven Reinhardt; Nicolai Stoye; Mathias Luderer; Falk Kiefer; Ulrich Schmitt; Klaus Lieb; Kristina Endres
Journal:  Sci Rep       Date:  2018-01-22       Impact factor: 4.379

6.  Chronic inhibition of dopamine β-hydroxylase facilitates behavioral responses to cocaine in mice.

Authors:  Meriem Gaval-Cruz; Larry Cameron Liles; Paul Michael Iuvone; David Weinshenker
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.